产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF2381, RRID:AB_2845395.
展开/折叠
C-t-PAK2; CB422; EC 2.7.11.1; Gamma PAK; Gamma-PAK; hPAK65; Kinase; p21 (CDKN1A) activated kinase 2; p21 (CDKN1A)-activated kinase 2a; p21 activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2; p21 protein Cdc42 Rac activated kinase 2; p21-activated kinase 2; p21-activated kinase, 65-KD; p21-activated protein kinase I; p21CDKN1A activated kinase 2; p27; p34; p58; p65PAK; PAK 2; PAK-2; PAK-2p34; Pak2; PAK2_HUMAN; PAK65; PAKgamma; S6 H4 kinase; S6/H4 kinase; Serine threonine protein kinase PAK 2; Serine/threonine protein kinase PAK 2;
抗原和靶标
Ubiquitously expressed. Higher levels seen in skeletal muscle, ovary, thymus and spleen.
- Q13177 PAK2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MSDNGELEDKPPAPPVRMSSTIFSTGGKDPLSANHSLKPLPSVPEEKKPRHKIISIFSGTEKGSKKKEKERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKLEQKKNPQAVLDVLKFYDSNTVKQKYLSFTPPEKDGFPSGTPALNAKGTEAPAVVTEEEDDDEETAPPVIAPRPDHTKSIYTRSVIDPVPAPVGDSHVDGAAKSLDKQKKKTKMTDEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTATDVALGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSYLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMEGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIMAAKEAMKSNR
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q13177 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S2 | Acetylation | Uniprot | |
S2 | Phosphorylation | Uniprot | |
S19 | Phosphorylation | Q13177 (PAK2) | Uniprot |
S20 | Phosphorylation | P54646 (PRKAA2) , Q13177 (PAK2) | Uniprot |
T21 | Phosphorylation | Uniprot | |
S24 | Phosphorylation | Uniprot | |
T25 | Phosphorylation | Uniprot | |
K28 | Acetylation | Uniprot | |
K28 | Ubiquitination | Uniprot | |
S32 | Phosphorylation | Uniprot | |
S36 | Phosphorylation | Uniprot | |
K38 | Acetylation | Uniprot | |
K38 | Ubiquitination | Uniprot | |
S42 | Phosphorylation | Uniprot | |
K52 | Ubiquitination | Uniprot | |
S55 | Phosphorylation | Q13177 (PAK2) | Uniprot |
S58 | Phosphorylation | Uniprot | |
T60 | Phosphorylation | Uniprot | |
K62 | Acetylation | Uniprot | |
K62 | Ubiquitination | Uniprot | |
S64 | Phosphorylation | Uniprot | |
S75 | Phosphorylation | Uniprot | |
T112 | Phosphorylation | Uniprot | |
K113 | Ubiquitination | Uniprot | |
K128 | Acetylation | Uniprot | |
K128 | Ubiquitination | Uniprot | |
Y130 | Phosphorylation | P12931 (SRC) | Uniprot |
S132 | Phosphorylation | Uniprot | |
T134 | Phosphorylation | Uniprot | |
K136 | Ubiquitination | Uniprot | |
Y139 | Phosphorylation | Uniprot | |
S141 | Phosphorylation | Q13177 (PAK2) | Uniprot |
T143 | Phosphorylation | Uniprot | |
K147 | Ubiquitination | Uniprot | |
S152 | Phosphorylation | Uniprot | |
T154 | Phosphorylation | Uniprot | |
T169 | Phosphorylation | Uniprot | |
K191 | Ubiquitination | Uniprot | |
S192 | Phosphorylation | Q13177 (PAK2) | Uniprot |
Y194 | Phosphorylation | Uniprot | |
T195 | Phosphorylation | Uniprot | |
S197 | Phosphorylation | Q13177 (PAK2) | Uniprot |
G213 | Myristoylation | Uniprot | |
K216 | Ubiquitination | Uniprot | |
S217 | Phosphorylation | Uniprot | |
K226 | Ubiquitination | Uniprot | |
T228 | Phosphorylation | Uniprot | |
K235 | Ubiquitination | Uniprot | |
K254 | Ubiquitination | Uniprot | |
K278 | Ubiquitination | Uniprot | |
K284 | Ubiquitination | Uniprot | |
K299 | Ubiquitination | Uniprot | |
K302 | Ubiquitination | Uniprot | |
K370 | Ubiquitination | Uniprot | |
S381 | Phosphorylation | Uniprot | |
T394 | Phosphorylation | Uniprot | |
K399 | Acetylation | Uniprot | |
K399 | Ubiquitination | Uniprot | |
S401 | Phosphorylation | Uniprot | |
T402 | Phosphorylation | Q13177 (PAK2) | Uniprot |
T406 | Phosphorylation | Uniprot | |
Y443 | Phosphorylation | Uniprot | |
Y453 | Phosphorylation | Uniprot | |
K468 | Ubiquitination | Uniprot | |
K487 | Ubiquitination | Uniprot | |
S490 | Phosphorylation | Uniprot | |
K492 | Acetylation | Uniprot | |
K492 | Ubiquitination | Uniprot | |
K501 | Acetylation | Uniprot | |
K501 | Ubiquitination | Uniprot | |
K504 | Ubiquitination | Uniprot | |
S507 | Phosphorylation | Uniprot | |
S522 | Phosphorylation | Uniprot |
翻译修饰 - Q13177 作为激酶
Substrate | Site | Source |
---|---|---|
P00519 (ABL1) | S618 | Uniprot |
P00519 (ABL1) | S619 | Uniprot |
P01106 (MYC) | T358 | Uniprot |
P01106 (MYC) | S373 | Uniprot |
P01106 (MYC) | T400 | Uniprot |
P01236 (PRL) | S179 | Uniprot |
P01236 (PRL) | S207 | Uniprot |
P05412 (JUN) | T2 | Uniprot |
P05412 (JUN) | T8 | Uniprot |
P05412 (JUN) | T89 | Uniprot |
P05412 (JUN) | T93 | Uniprot |
P05412 (JUN) | T286 | Uniprot |
P08670 (VIM) | S26 | Uniprot |
P08670 (VIM) | S39 | Uniprot |
P08670 (VIM) | S51 | Uniprot |
P08670 (VIM) | S66 | Uniprot |
P08670 (VIM) | S73 | Uniprot |
P17600-2 (SYN1) | S9 | Uniprot |
P19105 (MYL12A) | S19 | Uniprot |
P24844 (MYL9) | S20 | Uniprot |
P31152 (MAPK4) | S186 | Uniprot |
P35240 (NF2) | S518 | Uniprot |
P49023 (PXN) | S272 | Uniprot |
P49023 (PXN) | S274 | Uniprot |
P55210 (CASP7) | S30 | Uniprot |
P55210 (CASP7) | T173 | Uniprot |
P55210 (CASP7) | S239 | Uniprot |
P62753 (RPS6) | S235 | Uniprot |
P62753 (RPS6) | S236 | Uniprot |
P62753 (RPS6) | S240 | Uniprot |
P62753 (RPS6) | S242 | Uniprot |
P62805 (HIST4H4) | S48 | Uniprot |
Q04637 (EIF4G1) | S895 | Uniprot |
Q05682 (CALD1) | S714 | Uniprot |
Q05682 (CALD1) | S744 | Uniprot |
Q13177 (PAK2) | S19 | Uniprot |
Q13177 (PAK2) | S20 | Uniprot |
Q13177 (PAK2) | S55 | Uniprot |
Q13177 (PAK2) | S141 | Uniprot |
Q13177 (PAK2) | S192 | Uniprot |
Q13177 (PAK2) | S197 | Uniprot |
Q13177 (PAK2) | T402 | Uniprot |
Q15746 (MYLK) | S1208 | Uniprot |
Q15746 (MYLK) | S1759 | Uniprot |
Q15746-1 (MYLK) | S1760 | Uniprot |
Q15796 (SMAD2) | S417 | Uniprot |
Q16659 (MAPK6) | S189 | Uniprot |
Q70Z35 (PREX2) | S1107 | Uniprot |
Q9BUB5 (MKNK1) | S39 | Uniprot |
研究背景
Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Full-length PAK2 stimulates cell survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Phosphorylates JUN and plays an important role in EGF-induced cell proliferation. Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP. Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis. On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway. Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation.
Full-length PAK2 is autophosphorylated when activated by CDC42/p21. Following cleavage, both peptides, PAK-2p27 and PAK-2p34, become highly autophosphorylated, with PAK-2p27 being phosphorylated on serine and PAK-2p34 on threonine residues, respectively. Autophosphorylation of PAK-2p27 can occur in the absence of any effectors and is dependent on phosphorylation of Thr-402, because PAK-2p27 is acting as an exogenous substrate.
During apoptosis proteolytically cleaved by caspase-3 or caspase-3-like proteases to yield active PAK-2p34.
Ubiquitinated, leading to its proteasomal degradation.
PAK-2p34 is myristoylated.
Cytoplasm.
Note: MYO18A mediates the cellular distribution of the PAK2-ARHGEF7-GIT1 complex to the inner surface of the cell membrane.
Nucleus. Cytoplasm>Perinuclear region. Membrane>Lipid-anchor.
Note: Interaction with ARHGAP10 probably changes PAK-2p34 location to cytoplasmic perinuclear region. Myristoylation changes PAK-2p34 location to the membrane.
Ubiquitously expressed. Higher levels seen in skeletal muscle, ovary, thymus and spleen.
Interacts tightly with GTP-bound but not GDP-bound CDC42/p21 and RAC1. Interacts with SH3MD4. Interacts with SCRIB. Interacts with ARHGEF7 and GIT1. PAK-2p34 interacts with ARHGAP10. Interacts with RAC1.
(Microbial infection) Interacts with and activated by HIV-1 Nef.
Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
研究领域
· Cellular Processes > Cellular community - eukaryotes > Focal adhesion. (View pathway)
· Cellular Processes > Cell motility > Regulation of actin cytoskeleton. (View pathway)
· Environmental Information Processing > Signal transduction > MAPK signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > ErbB signaling pathway. (View pathway)
· Environmental Information Processing > Signal transduction > Ras signaling pathway. (View pathway)
· Human Diseases > Cancers: Specific types > Renal cell carcinoma. (View pathway)
· Organismal Systems > Development > Axon guidance. (View pathway)
· Organismal Systems > Immune system > T cell receptor signaling pathway. (View pathway)
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.